Evidence map›Paper›PMID 23295929›Full record

ArticleAntimicrobial agents and chemotherapy2013

MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.

Valentina Salas, F Javier Pastor, Deanna A Sutton, Enrique Calvo, Emilio Mayayo, Annette W Fothergill, Michael G Rinaldi, Josep Guarro

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Studies in mycology · 2021
    Review
  2. Treatment of Infections Due toJournal of fungi (Basel, Switzerland) · 2018
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Valentina SalasUnitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain.
F Javier Pastor
Deanna A Sutton
Enrique Calvo
Emilio Mayayo
Annette W Fothergill
Michael G Rinaldi
Josep Guarro
Institut d'Investigació Sanitària Pere Virgili · ESThe University of Texas Health Science Center at San Antonio · USUniversidad Rovira i Virgili · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the efficacy of voriconazole against nine strains of Aspergillus terreus with different MICs (0.12 to 4 μg/ml) by using a murine model. Markers of efficacy included survival, tissue burden, galactomannan antigenemia, and drug serum levels. Voriconazole was especially effective in prolonging survival and reducing the fungal load in infections by strains that showed MICs that were less than or equal to the epidemiological cutoff value (1 μg/ml). In vitro data might be useful for predicting the outcome of A. terreus infections.

Indexed as

Amphotericin BAnimalsAntifungal AgentsAspergillosisAspergillusDrug Resistance, FungalGalactoseMaleMannansMiceMicrobial Sensitivity TestsPrognosisPyrimidinesSurvival AnalysisTriazolesVoriconazoleAmphotericin BAntifungal AgentsgalactomannanGalactoseMannansPyrimidinesTriazolesVoriconazole

Identifiers

PMID23295929
PMCPMC3591889
OpenAlexW2043750602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.